CLINICAL_TRIALS
trial_result
· 2024-12-04
Clinical Trial Update: Safety and Pharmacokinetic Study of LMN-101 in Healthy Volunteers [Phase 1]
Summary
Phase 1 safety and pharmacokinetic data for LMN-101 were collected in healthy volunteers to assess safety and drug exposure.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Lumen Bioscience, Inc. | Conditions: Campylobacter Jejuni Infection | Phase 1 | Status: COMPLETED | Results posted: 2024-12-04